SCHEMBL17720902

SCHEMBL17720902

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4cccc(-c5cccc6c7ccccc7c7ccccc7c56)c4)c3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.50
KMT2A Q03164 9/20 0.50
MAPT P10636 6/20 0.50
ALDH1A1 P00352 4/20 0.50
HPGD P15428 4/20 0.50
LMNA P02545 3/20 0.50
KDM4E B2RXH2 2/20 0.50
NTSR1 P30989 1/20 0.45
GLA P06280 1/20 0.43
ADORA2A P29274 2/20 0.42
ADORA1 P30542 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ACHE P22303 1/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK10 P53779 1/20 0.40
MAOB P27338 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17720895 0.95 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL30021778 0.90 ALDH1A1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17720900 0.90 ALDH1A1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17299025 0.90 GP6 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22309531 0.89 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22309534 0.89 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL20038813 0.89 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17299019 0.89 ALDH1A1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16787504 0.89 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19501142 0.88 ALDH1A1 (0.42) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355224-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, and organic optoelectronic device and display device comprising same SAMSUNG SDI CO., LTD. (KR) 2019-07-16 US disclosed
US-10193081-B2 Organic compound for optoelectric device and composition for optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2019-01-29 US disclosed
EP-3015527-B1 ORGANIC COMPOUND FOR OPTOELECTRIC DEVICE AND COMPOSITION FOR OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2018-04-11 EP disclosed
US-20170346020-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2017-11-30 US disclosed
US-20170346020-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2017-11-30 US disclosed
US-20160126477-A1 ORGANIC COMPOUND FOR OPTOELECTRIC DEVICE AND COMPOSITION FOR OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-05-05 US disclosed
US-20160126477-A1 ORGANIC COMPOUND FOR OPTOELECTRIC DEVICE AND COMPOSITION FOR OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-05-05 US disclosed
EP-3015527-A1 ORGANIC COMPOUND FOR OPTOELECTRIC DEVICE AND COMPOSITION FOR OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE Samsung SDI Co., Ltd. (KR) 2016-05-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346020-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE COMPRISING SAME OR10J3, OXER1, OCIAD1 MEN1 3024/4885KMT2A 3969/4885MAPT 1199/4885
US-20160126477-A1 ORGANIC COMPOUND FOR OPTOELECTRIC DEVICE AND COMPOSITION FOR OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OCIAD2, OCIAD1 MEN1 2055/4885KMT2A 3817/4885MAPT 3198/4885
US-10193081-B2 Organic compound for optoelectric device and composition for optoelectric device and organic optoelectric device and display device OXER1, OCIAD2, OCIAD1 MEN1 2055/4885KMT2A 3817/4885MAPT 3198/4885
US-10355224-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, and organic optoelectronic device and display device comprising same OR10J3, OXER1, OCIAD1 MEN1 3024/4885KMT2A 3969/4885MAPT 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.